R-708-5p is a stress-regulated microRNA and a potential biomarker for the differential diagnosis of human mood disorders.
Tris Pharma has set its sights on an FDA filing ... and substance use disorder. Beam says its base-editing drug has met its goals in a phase 1/2 trial in genetic disease AATD, and it wants to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results